Trusted by leading healthcare providers worldwide
.png)
The global standard in brain imaging AI
Longitudinal brain MRI monitoring is crucial for timely diagnoses and life-changing therapeutic decisions - but tracking subtle changes can be challenging and time-consuming.
The AI-driven, validated, and FDA-cleared icobrain solutions assist radiologists and neurologists with comparing and quantifying brain MRI scans over time.
Disease-specific solutions that impact outcomes
%20(1).png)
.png)
%20(1).png)
%20(1).png)
%20(1).png)
%20(1).png)
%20(1).png)
Precision and personalized medicine are becoming the standard of care quickly in neurology. As brain MRI scans are a crucial part of the diagnosis and monitoring in neurology, the quantitative analysis of the icometrix’ AI-software together with the radiological reading are needed for a data-driven clinical decision-making in neurology
Precision and personalized medicine are becoming the standard of care quickly in neurology. As brain MRI scans are a crucial part of the diagnosis and monitoring in neurology, the quantitative analysis of the icometrix’ AI-software together with the radiological reading are needed for a data-driven clinical decision-making in neurology
Dr. Joseph Fritz
President of the American Society of Neuroimaging
.png)
.png)
.png)
What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.
What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.
Tiron Pechet, MD
Assistant Medical Director at Shields Healthcare
FDA cleared,
CE Marked Solutions
7
Hospitals using
our platform
400+
Countries our technology
is being used
30+
Care Enhanced
for patients
7K
Backed by evidence.
Proven in practice
#1
Validated AI solution for multiple sclerosis
9
FDA cleared solutions
>250
Scientific articles published
Backed by evidence.
Proven in practice
2.5x
Faster detection of treatment failure
40%
Increase in radiological reading speed
150%
Increased detection of disease activity in MS
68%
outcome improvement when employing icobrain® vs drugs alone
28
Countries with regulatory clearance
12
Awards
Integrating with these platforms
Latest news
Embedding imaging AI in your Alzheimer’s clinical workflow: From diagnosis to ARIA monitoring
The field of Alzheimer’s disease care is evolving rapidly . The approval of disease-modifying therapies have necessitated earlier...
GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions
The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of...
icobrain receives ACR Transparent AI badge: advancing trusted AI in neuroimaging
We are proud to announce that icobrain has been awarded the ACR Transparent AI badge by the American College of Radiology (ACR). This...
.png)
